1.
|
9 p, 1.6 MB |
Comparative Effectiveness Research in Localized Prostate Cancer : A 10-Year Follow-up Cohort Study
/
Garin, Olatz (Universitat Pompeu Fabra) ;
Suárez, J.F. (Hospital Universitari de Bellvitge) ;
Guedea, F. (Institut Català d'Oncologia) ;
Pont, À. (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Pardo Cladellas, Yolanda (Universitat Autònoma de Barcelona) ;
Goñi, A. (Institutu Onkologikoa) ;
Mariño, Alfonso (Servicio de Oncología Radioterápica. Centro Oncológico de Galicia) ;
Hervás, A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Herruzo, I. (Hospital Regional Universitario Carlos Haya (Málaga)) ;
Cabrera, Patricia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Ponce de León Roca, Javier (Institut d'Investigació Biomèdica Sant Pau) ;
Macías Hernández, Víctor (Hospital Universitari i Politècnic La Fe (València)) ;
Gutierrez, Cristina (Institut Català d'Oncologia) ;
Castells, M. (Hospital Universitari de Bellvitge) ;
Ferrer, M. (Universitat Autònoma de Barcelona)
Purpose: Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and evidence is lacking especially for brachytherapy. The aim of this study was to assess the long-term impact of the side effects of radical prostatectomy, brachytherapy, and external radiation therapy on patients with localized prostate cancer at 10 years, using propensity score analyses. [...]
2021 - 10.1016/j.ijrobp.2020.12.032
International Journal of Radiation Oncology Biology Physics, Vol. 110 Núm. 3 (january 2021) , p. 718-726
|
|
2.
|
11 p, 973.1 KB |
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review
/
Palacio-Vieira, Jorge (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Reyes-Urueña, Juliana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Imaz, Arkaitz (Hospital Universitari de Bellvitge) ;
Bruguera Riera, Andreu (Institut Germans Trias i Pujol) ;
Force, Lluís (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Orti Llaveria, Amat (Hospital de Tortosa Verge de la Cinta) ;
Llibre, Josep M.. (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Vilaró, Ingrid (Hospital General de Vic) ;
Homar Borràs, Francesc (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Falcó, Vicenç (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Riera, Melchor (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
de Lazzari, Elisa (Hospital Clínic i Provincial de Barcelona) ;
Miró, Josep M. (Hospital Clínic i Provincial de Barcelona) ;
Casabona-Barbarà, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Background: Despite remarkable achievements in antiretroviral therapy (ART), losses to follow-up (LTFU) might prevent the long-term success of HIV treatment and might delay the achievement of the 90-90-90 objectives. [...]
2021 - 10.1186/s12889-021-11613-y
BMC public health, Vol. 21 Núm. 1 (december 2021) , p. 1596
|
|
3.
|
4 p, 973.0 KB |
Long-term follow-up of recovered MPN patients with COVID-19
/
Barbui, Tiziano (Papa Giovanni XXIII Hospital) ;
Iurlo, Alessandra (Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Masciulli, Arianna (Papa Giovanni XXIII Hospital) ;
Carobbio, Alessandra (Papa Giovanni XXIII Hospital) ;
Ghirardi, Arianna (Papa Giovanni XXIII Hospital) ;
Rossi, Giuseppe (Spedali Civili) ;
Harrison, Claire (Guy's and St. Thomas' NHS Foundation Trust) ;
Alvarez-Larran, Alberto (Hospital Clínic i Provincial de Barcelona) ;
Elli, Elena María (Ospedale San Gerardo (Itàlia)) ;
Kiladjian, Jean-Jaques (Hospital Saint-Louis) ;
Gasior Kabat, Mercedes (Hospital Universitario La Paz (Madrid)) ;
Marin Sanchez, Alberto (Complejo Hospitalario Universitario de Albacete) ;
Palandri, Francesca (IRCCS Azienda Ospedaliero-Universitaria di Bologna) ;
Andrade-Campos, Marcio Miguel (Hospital del Mar (Barcelona, Catalunya)) ;
Vannucchi, Alessandro Maria (University of Florence) ;
Carreño-Tarragona, Gonzalo (Hospital Universitario 12 de Octubre (Madrid)) ;
Papadopoulos, Petros (Hospital Clínico San Carlos (Madrid)) ;
Quiroz Cervantes, Keina (Hospital Universitario de Móstoles (Madrid)) ;
Foncillas, Maria Angeles (Hospital Universitario Infanta Leonor) ;
Fox, Maria Laura (Vall d'Hebron Institut d'Oncologia) ;
Sagues Serrano, Miguel (Hospital de Sant Joan Despí Moisès Broggi) ;
Rumi, Elisa (University of Pavia) ;
Osorio, Santiago (Hospital General Universitario Gregorio Marañón) ;
Benevolo, Giulia (AOU Città della Salute e della Scienza di Torino) ;
Patriarca, Andrea (AOU Maggiore della Carità) ;
Navas Elorza, Begoña (Hospital Moncloa) ;
Garcia-Gutierrez, Valentín (Hospital Universitario Ramón y Cajal (Madrid)) ;
Magro Mazo, Elena (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Lunghi, Francesca (IRCCS Ospedale San Raffaele) ;
Bonifacio, Massimiliano (Ospedale Policlinico "G.B. Rossi". Borgo Roma) ;
De Stefano, Valerio (Fondazione Policlinico "A. Gemelli" IRCCS) ;
Hernandez-Boluda, Juan Carlos (Hospital Clínic Universitari (València)) ;
Lopez Abadia, Emma (Hospital General de Elche (Alicante)) ;
Angona, Anna (Hospital Universitari de Girona Doctor Josep Trueta) ;
Xicoy Cirici, Blanca (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ruggeri, Marco (Ospedale San Bortolo) ;
Koschmieder, Steffen (RWTH Aachen University) ;
Sobas, Marta Anna (Wroclaw Medical University) ;
Cuevas, Beatriz (Hospital Universitario de Burgos) ;
Cattaneo, Daniele (Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Daffini, Rosa (Spedali Civili) ;
Bellini, Marta (ASST Papa Giovanni XXIII) ;
Curto-Garcia, Natalia (Guy's and St. Thomas' NHS Foundation Trust) ;
Garrote, Marta (Hospital Clínic i Provincial de Barcelona) ;
Cavalca, Fabrizio (Hematology Division and Bone Marrow Transplant Unit. San Gerardo Hospital. ASST Monza) ;
Benajiba, Lina (Hospital Saint-Louis) ;
Bellosillo Paricio, Beatriz (Hospital del Mar (Barcelona, Catalunya)) ;
Guglielmelli, Paola (University of Florence) ;
Borsani, Oscar (University of Pavia) ;
Betti, Silvia (Fondazione Policlinico "A. Gemelli" IRCCS) ;
Salmoiraghi, Silvia (ASST Papa Giovanni XXIII) ;
Rambaldi, Alessandro (Università degli Studi di Milano) ;
Universitat Autònoma de Barcelona
2021 - 10.1038/s41408-021-00509-0
Blood Cancer Journal, Vol. 11 Núm. 6 (june 2021) , p. 115
|
|
4.
|
10 p, 1.1 MB |
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial
/
Perl, Alexander E. (University of Pennsylvania) ;
Larson, Richard A (University of Chicago) ;
Podoltsev, Nikolai A. (Yale School of Medicine) ;
Strickland, Stephen. (Vanderbilt-Ingram Cancer Center) ;
Wang, Eunice S. (Roswell Park Comprehensive Cancer Center) ;
Atallah, Ehab (Cancer Center-Froedtert Hospital) ;
Schiller, Gary J. (David Geffen School of Medicine at UCLA) ;
Martinelli, Giovanni (IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori,") ;
Neubauer, Andreas (Universitätsklinikum Giessen und Marburg GmbH) ;
Sierra, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Montesinos, Pau (Hospital Universitari i Politècnic La Fe (València)) ;
Récher, Christian (Centre Hospitalier Universitaire de Toulouse) ;
Yoon, Sung Soo (Seoul National University Hospital) ;
Hosono, Naoko (University of Fukui) ;
Onozawa, Masahiro (Hokkaido University) ;
Chiba, Shigeru (University of Tsukuba) ;
Kim, Hee-Je (Catholic Hematology Hospital) ;
Hasabou, Nahla (Astellas Pharma US. Inc) ;
Lu, Qiaoyang (Astellas Pharma US. Inc) ;
Tiu, Ramon (Astellas Pharma US. Inc) ;
Levis, Mark (Johns Hopkins University) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
The phase 3 ADMIRAL (NCT02421939; Study ID: 2215-CL-0301) trial showed superior overall survival in patients with relapsed/refractory FLT3-mutation-positive acute myeloid leukemia (AML) randomized 2:1 to receive the oral FMS-like tyrosine kinase 3 inhibitor gilteritinib vs those randomized to receive salvage chemotherapy (SC). [...]
2022 - 10.1182/blood.2021011583
Blood, Vol. 139 Núm. 23 (june 2022) , p. 3366-3375
|
|
5.
|
10 p, 1.1 MB |
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
/
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Mikulska, Malgorzata (Division of Infectious Diseases. University of Genoa and Ospedale Policlinico San Martino) ;
Tridello, G. (Pediatric Hematology Oncology) ;
Aguado, Beatriz (Instituto de Investigación Hospital Universitario de la Princesa) ;
Zahrani, M.A. (King Abdul - Aziz Medical City) ;
Apperley, Jane (Centre for Haematology. Imperial College) ;
Berceanu, A. (Hopital Jean Minjoz) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ;
Ciceri, Fabio (Ospedale San Raffaele s.r.l.) ;
Lopez-Corral, L. (Hematology Department. Complejo Asistencial Universitario de Salamanca-IBSAL; Centro de Investigación del Cáncer-IBMCC) ;
Crippa, C. (Spedali Civili) ;
Fox, M.L. (Vall d'Hebron Institut d'Oncologia) ;
Grassi, A. (ASST Papa Giovanni XXIII) ;
Jimenez, M.J. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Demir, S.K. (HSCT unit. Demiroglu Bilim University) ;
Kwon, Mi (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Llamas, C.V. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
Lorenzo, J.L.L. (Hospital Universitario Fundación Jiménez Díaz) ;
Mielke, S. (Karolinska Institutet (Estocolm, Suècia). Department of Laboratory Medicine) ;
Orchard, K. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Porras, R.P. (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Vallisa, D. (Hospital Guglielmo da Saliceto) ;
Xhaard, A. (Hôpital St. Louis) ;
Knelange, N.S. (EBMT Data Office. Department of Medical Statistics & Bioinformatics) ;
Cedillo, Angel (GETH Spanish Registry) ;
Kroeger, Nicolaus (Department of Stem cell Transplantation. University Hospital Eppendorf) ;
Piñana, José Luis (Hospital Clínic Universitari (València)) ;
Styczynski, Jan (Pediatric Hematology and Oncology. University Hospital. Collegium Medicum. Nicolaus Copernicus University Torun)
This study reports on 382 COVID-19 patients having undergone allogeneic (n = 236) or autologous (n = 146) hematopoietic cell transplantation (HCT) reported to the European Society for Blood and Marrow Transplantation (EBMT) or to the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH). [...]
2021 - 10.1038/s41375-021-01302-5
Leukemia, Vol. 35 Núm. 10 (october 2021) , p. 2885-2894
|
|
6.
|
11 p, 1.5 MB |
Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis : interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up
/
Papp, Kim A (K Papp Clinical Research and Probity Medical Research) ;
Lebwohl, M. G. (Icahn School of Medicine at Mount Sinai) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Ohtsuki, M. (Jichi Medical University) ;
Beissert, Stefan (Department of Dermatology. University Hospital Carl Gustav Carus. TU Dresden) ;
Zeng, J. (AbbVie Inc.) ;
Rubant, S. (AbbVie Inc.) ;
Sinvhal, R. (AbbVie Inc.) ;
Zhao, Y. (AbbVie Inc.) ;
Soliman, A.M. (AbbVie Inc.) ;
Alperovich, G. (AbbVie Inc.) ;
Leonardi, C. (Central Dermatology. Richmond Heights)
Background: Psoriasis is a chronic inflammatory skin disease requiring prolonged treatment. New biologic therapies require long-term evaluation to assess the durability of their efficacy and safety profiles over time. [...]
2021 - 10.1111/bjd.20595
British journal of dermatology, Vol. 185 Núm. 6 (december 2021) , p. 1135-1145
|
|
7.
|
8 p, 732.8 KB |
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
/
Gagelmann, N. (University Medical Center Hamburg-Eppendorf) ;
Eikema, D. J. (EBMT Statistics) ;
Stelljes, M. (University of Münster) ;
Beelen, D. (University Hospital Essen (Alemanya)) ;
de Wreede, Liesbeth C (EBMT Statistics) ;
Mufti, G. (GKT School of Medicine) ;
Knelange, N. S. (EBMT Data Office) ;
Niederwieser, D. (University Hospital Leipzig) ;
Friis, L. S. (University of Copenhagen) ;
Ehninger, Gerhard (Universitätsklinikum Dresden) ;
Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ;
Yakoub-Agha, Ibrahim (Université Lille2) ;
Meijer, E. (Amsterdam UMC. University Medical Center) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Kanz, L. (Universität Tübingen) ;
Lopez-Corral, L. (Hospital Clínico Universitario (Salamanca)) ;
Brecht, A. (Deutsche Klinik für Diagnostik) ;
Craddock, Charles (Centre for Clinical Haematology) ;
Finke, J. (University of Freiburg) ;
Cornelissen, J. J. (Erasmus MC Cancer Institute. Erasmus University Medical Center) ;
Bernasconi, P. (Fondazione IRCCS Policlinico San Matteo) ;
Chevallier, Patrice (CHU Nantes) ;
Sierra, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Robin, M. (Hopital St. Louis) ;
Kroeger, Nicolaus (University Medical Center Hamburg-Eppendorf) ;
Universitat Autònoma de Barcelona
The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with myelodysplastic syndromes reported to the European Society for Blood and Marrow Transplantation registry. [...]
2019 - 10.3324/haematol.2018.200808
Haematologica, Vol. 104 Núm. 5 (30 2019) , p. 929-936
|
|
8.
|
11 p, 497.0 KB |
Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
/
Matas, Jessica (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Llorenç, Victor (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Fonollosa, Alex (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Esquinas, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Diaz Valle, David (Hospital Clínico San Carlos (Madrid)) ;
Berasategui, Barbara (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Mesquida, Marina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Artaraz, Joseba (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Ríos, José (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Adan Civera, Alfredo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Universitat Autònoma de Barcelona
Aims We aimed to investigate predictive factors for visual and anatomic outcomes in patients with macular edema secondary to non-infectious uveitis. Material and methods We conducted a multicenter, prospective, observational, 12-month follow-up study. [...]
2019 - 10.1371/journal.pone.0210799
PloS one, Vol. 14 Núm. 1 (january 2019) , p. e0210799
|
|
9.
|
16 p, 1.1 MB |
Tuberculosis incidence among infected contacts detected through contact tracing of smear-positive patients
/
Martin-Sánchez, Mario (Agència de Salut Pública de Barcelona) ;
Brugueras Torrella, Silvia (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ;
De Andrés, Anna (Agència de Salut Pública de Barcelona) ;
Simon, Pere (Agència de Salut Pública de Barcelona) ;
Gorrindo, Pilar (Agència de Salut Pública de Barcelona) ;
Ros, Miriam (Agència de Salut Pública de Barcelona) ;
Masdeu, Eva (Agència de Salut Pública de Barcelona) ;
Millet, Joan-Pau (Fundació de la Unitat d'Investigació en Tuberculosi de Barcelona) ;
Caylà, Joan A.. (Fundació de la Unitat d'Investigació en Tuberculosi de Barcelona) ;
Orcau, Àngels (Fundació de la Unitat d'Investigació en Tuberculosi de Barcelona)
Background The contacts of people with pulmonary tuberculosis (PTB) have a high risk of becoming infected and developing tuberculosis (TB). Our aim was to determine the incidence of TB and its risk factors in a cohort of contacts with latent TB infection (LTBI) detected through contact tracing of smear-positive PTB cases. [...]
2019 - 10.1371/journal.pone.0215322
PloS one, Vol. 14 Núm. 4 (april 2019) , p. e0215322
|
|
10.
|
13 p, 1.2 MB |
Low, borderline and normal ankle-brachial index as a predictor of incidents outcomes in the Mediterranean based-population ARTPER cohort after 9 years follow-up
/
Alzamora, M. Teresa (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Forés Raurell, Rosa (Universitat Autònoma de Barcelona) ;
Pera, Guillem (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Baena Díez, José Miguel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Valverde, Marta (Hospital Nostra Senyora de Meritxell (Principat d'Andorra)) ;
Torán, Pere (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Background Guidelines recommended adopting the same cardiovascular risk modification strategies used for coronary disease in case of low Ankle-brachial index (ABI), but here exist few studies on long-term cardiovascular outcomes in patients with borderline ABI and even fewer on the general population. [...]
2019 - 10.1371/journal.pone.0209163
PloS one, Vol. 14 Núm. 1 (january 2019) , p. e0209163
|
|